Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Programmed Cell Death 1 Ligand 1(PDL1, PD-L1)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04274023
What this trial is testing

Study on TSR-042 in Advanced Clear Cell Sarcoma

Who this might be right for
Sarcoma, Clear Cell
Italian Sarcoma Group 3
Not applicableLooking for participantsNCT07249060
What this trial is testing

Interferon Signature in Anti-CTLA-4 and Anti-PD-1/PD-L1-Treated Cancer Patients Compared With Systemic Autoimmune Disease Patients

Who this might be right for
Immune-Related Adverse EventsLupus Erythematosus, SystemicSjogren Syndrome+3 more
Hospital Universitario Araba 300
Testing effectiveness (Phase 2)Study completedNCT04465890
What this trial is testing

A Phase II Study of Subcutaneously Injected PD-L1 Antibody ASC22 in Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis b
Ascletis Pharmaceuticals Co., Ltd. 207
Large-scale testing (Phase 3)Active Not RecruitingNCT05499390
What this trial is testing

AK112 in Advanced Non-Small Cell Lung Cancer

Who this might be right for
Advanced Non-small-cell Lung Cancer
Akeso 398
Large-scale testing (Phase 3)Active Not RecruitingNCT04550260
What this trial is testing

Study of Durvalumab Versus Placebo in Combination With Definitive Chemoradiation Therapy in Patient With ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
AstraZeneca 640
Testing effectiveness (Phase 2)Ended earlyNCT03376659
What this trial is testing

Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic Adenocarcinoma

Who this might be right for
Metastatic Colorectal CancerColorectal AdenocarcinomaPancreatic Adenocarcinoma+1 more
Georgetown University 8
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07762703
What this trial is testing

Combination Immunotherapy Treatment for Locally Advanced Unresectable or Metastatic, PD-L1 Negative (CPS<10), gBRCA Negative, Triple Negative Breast Cancer Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 Therapy

Who this might be right for
Triple-Negative Breast Cancer (TNBC)
BreakBio Corp 10
Testing effectiveness (Phase 2)Looking for participantsNCT06580574
What this trial is testing

Immune Checkpoint Inhibitors for Organ Preservation in Non-metastatic dMMR/MSI-H Gastric or Colon Cancers

Who this might be right for
Gastric CancerColon CancerMSI-H+1 more
Peking University 34
Early research (Phase 1)Study completedNCT03517488
What this trial is testing

XmAb®20717 in Subjects With Selected Advanced Solid Tumors

Who this might be right for
MelanomaBreast CarcinomaHepatocellular Carcinoma+25 more
Xencor, Inc. 150
Testing effectiveness (Phase 2)Looking for participantsNCT06941857
What this trial is testing

NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20
Not applicableLooking for participantsNCT06227728
What this trial is testing

Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer.

Who this might be right for
Non Small Cell Lung CancerBreast CancerColorectal Cancer+4 more
Gene Solutions 50
Large-scale testing (Phase 3)Study completedNCT03084471
What this trial is testing

An Open-Label, Multi-Centre, Study to Assess the Safety of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies.

Who this might be right for
Advanced Solid Malignancies
AstraZeneca 867
Large-scale testing (Phase 3)Study completedNCT04676412
What this trial is testing

Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) in Adults With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Treatment-naïve Nonsmall Cell Lung Cancer (NSCLC) [MK-7902-007/E7080-G000-314/LEAP-007] - China Extension Study

Who this might be right for
Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC 107
Testing effectiveness (Phase 2)Looking for participantsNCT07106892
What this trial is testing

Phase II, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of HLX43 (an Anti-PD-L1 ADC) in Subjects With Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer (CRC)
Shanghai Henlius Biotech 60
Testing effectiveness (Phase 2)WithdrawnNCT03197571
What this trial is testing

QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy

Who this might be right for
Urothelial Carcinoma
ImmunityBio, Inc.
Early research (Phase 1)Ended earlyNCT04156100
What this trial is testing

A Study in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Agenus Inc. 19
Very early researchUnknownNCT03371992
What this trial is testing

Pilot Study of Nilogen 3D-EX and Its Ability to Predict Therapeutic Response to Anti-PD1 or Anti-PDL1 in NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Nilogen Oncosystems 25
Testing effectiveness (Phase 2)Ended earlyNCT03440437
What this trial is testing

FS118 in Patients With Advanced Malignancies

Who this might be right for
Advanced CancerMetastatic CancerSquamous Cell Carcinoma of Head and Neck
invoX Pharma Limited 80
Large-scale testing (Phase 3)Active Not RecruitingNCT04634877
What this trial is testing

Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)

Who this might be right for
Endometrial Neoplasms
Merck Sharp & Dohme LLC 990
Testing effectiveness (Phase 2)Ended earlyNCT03666728
What this trial is testing

SHR-1210 in Combination With BP102 in Subjects With Non-squamous NSCLC

Who this might be right for
Lung Neoplasms
Jiangsu HengRui Medicine Co., Ltd. 5
Next Page